NEO | NeoGenomicsNASDAQIndustrialsCommon stock golden cross and death cross projections, cross tests and history

$16.83
+$0.34 (+2.06%)

NeoGenomics (NEO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both. On the weekly a golden cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $16.83 vs 50 $17.68 / 200 $12.82
Projection
No cross projected
Test
No active test
Last cross
Golden cross 2 Jul 2026 ยท projected 23 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $17.38 vs 50 $12.69 / 200 $13.31
Projection
Golden cross projected in 6 bars
Test
No active test
Last cross
Death cross week of 13 Jun 2022 ยท projected 29 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $16.83 vs 50 $17.04 / 200 $16.11
Projection
No cross projected
Test
No active test
Last cross
Golden cross 10 Jun 2026 ยท projected 27 bars out

Cross history

30
crosses on record since 2017
15 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Jul 2026Golden steepdaily23 bars outNot tested
10 Jun 2026Golden4-hour27 bars outNot tested
13 Apr 2026Death steepdaily30 bars outNot tested
2 Mar 2026Death4-hour22 bars outNot tested
4 Nov 2025Golden steepdaily30 bars outNot tested

About NEO

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$28.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorIndustrials
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.